Heraeus

Heraeus is a global technology group that is family-owned and diversified across multiple sectors, including precious metals, pharmaceuticals, and materials. The company specializes in providing technologically advanced solutions designed to enhance competitiveness for its clients in various industries such as electronics, automotive, chemical, pharmaceutical, medical, and renewable energy. Among its offerings, Heraeus Medical manufactures orthopedic bone cements, mixing systems, and preformed spacers specifically for total joint arthroplasty and revision procedures. By focusing on innovation and quality, Heraeus aims to deliver products and solutions that address the evolving needs of its customers and support long-term growth.

Frank Stietz

COO

17 past transactions

CSMH

Corporate Round in 2024
Compound Semiconductor (Xiamen) Technology Co., Ltd. is an advanced semiconductor manufacturing technology based joint venture company invested from the Korea, China and Singapore, registered in the city of Xiamen, China. We have equipped with advanced semiconductor manufacturing tools including MPCVD, MOCVD, LPCVD, HVPE and high temperature PVD to produce high quality Diamond wafer and AlN template on various substrate including Si, sapphire, and polished diamond. Our mission is to be the most advanced compound semiconductor company in the global market, contributing to the related technology development. We have strong R&D team and actively collaborate with best research group around the world. Currently, we are providing the thermal grade polycrystalline diamond, which can be used as an effective heat sink aims to solve the heat issue in temperature sensitive device, such as power devices, lasers and avalanche photodiodes etc. We also provides wafer scale polished diamond with sub-nanometer RMS surface roughness, which might be suitable for the integration of GaN, GaO and AlN epilayers and devices on Diamond via direct bonding or heteoepitaxy.

Tsubame BHB

Series C in 2024
Tsubame BHB Co., Ltd. is a Tokyo-based company that specializes in the research, development, and manufacturing of on-site ammonia production systems and catalysts. Founded in 2017, Tsubame focuses on commercializing ammonia synthesis through innovative electride catalyst technology, which allows for flexible production conditions. The company's systems are designed for small-scale plants, addressing critical environmental and food-related challenges while promoting a sustainable society. By enabling on-site ammonia production, Tsubame aims to reduce transportation and storage costs for its clients, contributing to more efficient resource management.

Holosolis

Corporate Round in 2023
Holosolis is a European manufacturer specializing in the production of photovoltaic modules. Its mission is to support the EU's energy sovereignty objectives and combat global warming. The company aims to construct Europe's largest photovoltaic panel factory, offering a scalable, low-carbon footprint, and socially responsible solution to meet the increasing demand for renewable energy.

aiXscale Photonics

Corporate Round in 2023
aiXscale Photonics provides unique ultra-high precision optical glass interposer solutions for the building of transceiver optical subassemblies and co-packaged optics that are dependable, low loss, and cost-effective. We meet the demands of today's and tomorrow's high-volume data and telecommunications applications.

Smart Steel Technologies

Venture Round in 2023
Smart Steel Technologies GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence software aimed at optimizing steel production and processing. The company's AI solutions focus on enhancing quality control, energy efficiency, and CO2 management within the steel manufacturing sector, which includes applications in automotive and construction. Smart Steel Technologies offers a temperature optimization AI that predicts live temperature behavior during the casting process, helping steelmakers eliminate inconsistencies and maintain high-quality casting sequences. The company reports process efficiency improvements of 5-10% at various stages of production and provides integration support, collaborating with metallurgists, process engineers, and AI specialists to help clients achieve their optimization goals while reducing casting defects and overall quality costs.

MimiX Biotherapeutics

Seed Round in 2022
MimiX Biotherapeutics Sàrl is a Swiss company founded in 2016 that specializes in biofabrication technology focused on tissue manufacturing for therapeutic and diagnostic applications. Based in La Tène, the company aims to revolutionize regenerative and personalized medicine through its innovative point-of-care approach. By developing ultra-fast biomanufacturing technology, MimiX Biotherapeutics seeks to create patient-specific biological tissue equivalents, facilitating tailored treatments that meet individual medical needs.

Revalyu Resources GmbH

Acquisition in 2022
Plastic Bottle Recycling Revalyu has commercialized a breakthrough chemical plastic bottle recycling technology. This is a revolutionary and innovative PET recycling process. Single-use plastic no longer needs to be considered waste but rather a valuable resource.

ETS Wound Care

Acquisition in 2021
ETS Wound Care is focused on applying borate-based bioactive glass technology to a broad range of breakthrough solutions.

Mo-Sci

Acquisition in 2021
Mo-Sci Corporation is a biotechnology company specializing in high-quality precision glass technology and the manufacture of specialty glasses. The company produces a diverse range of products, including glass microspheres, fibers, powders, and frit, which are utilized across various sectors such as healthcare, automotive, aerospace, and pharmaceuticals. Mo-Sci's offerings include bioactive glass, sealing and porous silica glasses, and technical glass powders, enabling them to provide customized solutions tailored to the specific needs of their clients. By focusing on innovation in specialty glass applications, Mo-Sci serves industries that require advanced materials for a variety of uses, including dental, wound care, and electronic applications.

Contract Medical International

Acquisition in 2020
Contract Medical International GmbH, founded in 2000 and based in Dresden, Germany, specializes in low-cost manufacturing and related services for the medical industry. The company focuses on providing product development, regulatory guidance, and contract manufacturing services for minimally invasive medical devices used in various applications, including cardiology, endoscopy, neurosurgery, and gastrointestinal and respiratory fields. CMI emphasizes its engineering expertise and regulatory knowledge, supported by a state-of-the-art infrastructure and a mature quality management system certified to ISO 13485 standards. As a subsidiary of Heraeus Medical Components, Contract Medical International supports its clients in bringing new medical devices to market in Europe, the United States, and other regions.

Via Biomedical

Acquisition in 2019
Via Biomedical, Inc. specializes in the design, development, and manufacturing of medical devices, particularly focusing on catheter systems and related products. Founded in 2001 and based in Maple Grove, Minnesota, the company offers a comprehensive range of services, including contract manufacturing for catheter systems, medical balloons, delivery systems, and custom devices. In addition to manufacturing, Via Biomedical provides extensive mechanical testing services, encompassing tensile, leak, pressure, and dimensional testing, among others, for catheter-based systems. The company also supports product design and development, as well as project management, ensuring that clients receive fully validated products and ongoing manufacturing support. As a subsidiary of Heraeus Medical Components LLC, Via Biomedical emphasizes quality and innovation in serving medical original equipment manufacturers (OEMs) globally.

Forciot

Seed Round in 2019
Forciot is a Finnish technology company founded in December 2015, specializing in advanced sensor technology for the Internet of Things (IoT). Emerging from a collaboration between leading wearable researchers from Tampere University of Technology and consumer electronics experts, Forciot aims to revolutionize the wearable technology landscape. The company envisions a future where measurement technologies are seamlessly integrated into everyday sporting products, such as shoes and gloves, eliminating the need for separate devices. Forciot provides business-to-business customers with innovative solutions that enable real-time measurement of force, power, pressure, balance, and weight. Their advanced stretchable electronics and algorithms allow manufacturers to harness valuable data on strength and performance, positioning Forciot as an engineering partner for those looking to develop next-generation IoT products.

Evergreen Medical Technologies

Acquisition in 2018
Evergreen Medical Technologies specializes in the development and manufacturing of active implantable medical devices. The company serves as a contract and original equipment manufacturer (OEM) for a variety of medical device clients, providing comprehensive product development resources. Its offerings include design, development, testing, and manufacturing services across several clinical areas, including cardiac, vascular, neuromodulation, and gastroenterology. Evergreen Medical Technologies is committed to facilitating a rapid time to market for its clients' next medical device innovations.

Biotectix

Acquisition in 2017
Biotectix, LLC is a company that specializes in the development and commercialization of bioactive conductive polymer electrodes and coatings for medical devices. Founded in 2007 and based in Richmond, California, Biotectix produces innovative products such as Amplicoat, which optimizes communication between human tissue and medical device electrodes, and Tecticoat, a conductive coating for textiles and materials that provides electrical conductivity and shielding. Their products are utilized in a wide range of medical devices, including retinal and cochlear prostheses, pacemakers, biosensors, and deep brain stimulators. Biotectix primarily serves medical device manufacturers, offering solutions that enhance device stability, minimize foreign body reactions, and improve long-term electrical performance. As of September 2017, Biotectix operates as a subsidiary of Heraeus Medical Components LLC.

Ankasa Regenerative Therapeutics

Series A in 2015
Ankasa Regenerative Therapeutics is a biopharmaceutical company based in La Jolla, California, founded in 2014. The company focuses on enhancing tissue healing by reactivating stem cells. It develops proprietary formulations of a potent WNT stem cell activator, aiming to accelerate tissue repair in various degenerative conditions affecting bone, cartilage, skin, muscle, vasculature, and the central nervous system. Ankasa's approach has shown superior bone reformation compared to existing standards of care in preclinical models. The company's therapies are designed to improve tissue repair and regeneration, particularly enhancing the osteogenic properties of patient-derived stem cells used in reconstructive surgeries. This aims to reduce revision surgery rates and associated complications.

Locate Bio

Seed Round in 2014
Locate Bio Limited is a regenerative medicine and device company based in Nottingham, United Kingdom, focused on developing innovative solutions for tissue repair. It has created a regenerative medicine platform that utilizes Targeted, Orchestrated Signaling technology, allowing for precise therapeutic signal delivery at the site of injury. This platform offers control over microenvironmental cues for cell therapies and supports tissue repair by accommodating various therapeutic agents. The company's clinical-stage product, LDGraft, is designed for the treatment of chronic low back pain, while another product, CognitOss, is in the discovery phase for addressing antimicrobial-resistant infections. Locate Bio's products are applicable across multiple medical disciplines, including cardiology, neurology, orthopedics, dentistry, and reconstructive surgery. Originally named Locate Therapeutics Limited, the company rebranded to Locate Bio Limited in October 2018 and has been operational since 2001.

Clevios Conductive Polymers

Acquisition in 2010
Clevios Conductive Polymers are chemicals used in a wide range of applications, primarily in the electronics industry.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.